Skip to playerSkip to main content
  • 10 hours ago
Oura expects sales to nearly double to $2B in 2026 as it expands globally and invests in AI-driven health insights. The company is focused on women’s health, preventative care, and new biometric partnerships, but says there is currently no IPO plan.

Category

🗞
News
Transcript
00:00It's Benzinga, bringing Wall Street to Main Street.
00:03Oura CEO Tom Hale told CNBC the Finnish wearable tech company expects to generate
00:07close to $2 billion in sales in 2026, nearly doubling projected 2025 revenue of $1 billion.
00:15The growth follows a $900 million October funding round and ongoing investments in
00:20artificial intelligence and global expansion. CEO Tom Hale told CNBC that Oura's growth is
00:26driven by its successful women's health features and international expansion.
00:30Valued at $11 billion, Oura is enhancing its AI capabilities, introducing tools like the
00:35Oura Advisor chatbot for personalized health insights and pursuing partnerships in fertility,
00:41glucose, and blood pressure monitoring. Hale said the company remains focused on preventative
00:46healthcare but has no news on an IPO. For all things money, visit Benzinga.com.
Be the first to comment
Add your comment

Recommended